The use of gene therapy vs. corticotomy surgery in accelerating orthodontic tooth movement
- 20 July 2011
- journal article
- research article
- Published by Wiley in Orthodontics & Craniofacial Research
- Vol. 14 (3) , 138-148
Abstract
To cite this article: Iglesias‐Linares A, Moreno‐Fernandez AM, Yañez‐Vico R, Mendoza‐Mendoza A, Gonzalez‐Moles M, Solano‐Reina E: The use of gene therapy vs. corticotomy surgery in accelerating orthodontic tooth movement Orthod Craniofac Res 2011;14:138–148Structured Authors – Iglesias‐Linares A, Moreno‐Fernandez AM, Yañez‐Vico R, Mendoza‐Mendoza A, Gonzalez‐Moles M, Solano‐Reina EObjective – Alveolar corticotomy surgery is an adjunctive therapy for reducing orthodontic treatment duration. The activation pathways of bone resorption involved in the tooth movement (TM) process are directly linked to the receptor activator of the nuclear factor‐kB ligand (RANKL). Whether similar molecular pathways through RANKL, are shared by the acceleratory TM process (corticotomy‐induced or not), sustained acceleration would therefore be expected with transgenic overexpression of this factor. We hypothesize that maintaining transgenic overexpression of RANKL will accelerate TM under force over time rather than at the beginning of therapy only; this contrasts with the corticotomy procedure.Material and Methods – We transfected the pcDNA3.1(+)‐mRANKL transgene in vitro into NIH3T3 cells, then evaluated by PCR, Western blot and ex vivo resorption assay. Quantification of RANKL immunofluorescence, fluorescence‐based tartrate‐resistant acid phosphatase+ (TRAP+) osteoclast counts and histological analyses of the bone resorption area were performed and clinically correlated after a 32‐day in vivo experiment comparing corticotomy and gene therapy.Results – In vitro experiments resulted in increased level of RANKL protein (46%, p < 0.05) and greater mineral resorption (39%, p < 0.05) compared to the controls. In vivo results showed increased RANKL immunoexpression for both corticotomy (twofold) and transfection groups (threefold) after 10 days. After 32 days, a similar result was obtained for the transfected group but not for the surgery group. These data correlate with the clinical effect of decelerating TM in the surgery group.Conclusions – Selective gene therapy with RANKL has been experimentally tested as an alternative method to corticotomy surgery, showing higher effectiveness than surgical methods used for acceleratory purposes in orthodontics.Keywords
This publication has 27 references indexed in Scilit:
- Extracellular Signal-Regulated Kinase 1 (ERK1) and ERK2 Play Essential Roles in Osteoblast Differentiation and in Supporting OsteoclastogenesisMolecular and Cellular Biology, 2009
- Expression of receptor activator of nuclear factor‐κB ligand by B cells in response to oral bacteriaOral Microbiology and Immunology, 2009
- Effects of Corticision on Paradental Remodeling in Orthodontic Tooth MovementThe Angle Orthodontist, 2009
- iNOS -derived Nitric Oxide Modulates Infection-stimulated Bone LossJournal of Dental Research, 2008
- Modeling of Trabecular Bone and Lamina Dura Following Selective Alveolar Decortication in RatsJournal of Periodontology, 2008
- Osteoclast differentiation during experimental tooth movement by a short-term force application: An immunohistochemical study in ratsActa Odontologica Scandinavica, 2008
- Bone formation and tooth movement are synergistically enhanced by administration of EP4 agonistAmerican Journal of Orthodontics and Dentofacial Orthopedics, 2007
- Acceleration of orthodontic tooth movement by alveolar corticotomy in the dogAmerican Journal of Orthodontics and Dentofacial Orthopedics, 2007
- Tissue reaction to orthodontic tooth movement in acute and chronic corticosteroid treatment*Orthodontics & Craniofacial Research, 2004
- The Effect of Prostaglandins on Experimental Tooth Movement in Monkeys (Macaca fuscata)Journal of Dental Research, 1982